Clinical Trial Update: Improving Health of Patients With Colon Cancer Following Surgery: A Trial of SA-ICAN Via Videoconferencing

View source ↗

Summary

A clinical trial evaluating SA-ICAN for improving health in colon cancer patients after surgery via videoconferencing has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• SA-ICAN

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colon Cancer | Status: TERMINATED